• EOC Pharma Group

  Participated · Series B · Nov 2017

  EOC Pharma focuses on developing in-licensed oncology drugs for the China market. The company acquires or in-licenses cancer therapies and advances them through development in China. Its near-term plan, as reported, is to progress those in-licensed oncology candidates within China. The article reports a $71 million Series C financing to support that China-focused development. No operating metrics, revenue figures, pipeline details, or partnership names were disclosed in the article. EOC Pharma is a fast-growing, Shanghai-based biopharmaceutical company that in-licenses innovative global oncology products and develops, manufactures and commercializes them for China. The company has a pipeline of six novel products from global biopharmaceutical partners, including two innovative small molecules expected to enter Phase 3 registration studies in China in 2018 for breast cancer and gastric cancer. Its pipeline also includes innovative biologics being developed for indications in immuno-oncology and tumor metastasis. EOC is building a fully integrated manufacturing, development and commercialization platform and is a spin-off of the oncology division of Eddingpharm. The company plans to use new funding to advance its mid- and late-stage clinical pipeline and to in-license additional late-stage oncology assets. Management highlights a track record in strategic partnering and commercialization in China and intends to leverage an improved clinical and regulatory environment and a rapidly growing healthcare market.

• One

  Led · Series B · Jun 2017

  One Inc provides a unified digital payments platform designed to integrate with modern and legacy insurance core systems, consolidating premium payments and claims disbursements into a single network. The company engages policyholders across multi-channel communications while securely processing payments and supporting complex insurance use cases. One Inc reports close to 500 employees, handles annual payments of USD 70 billion, serves over 240 insurer customers, and maintains a vendor network of more than 700,000. It has demonstrated over 65% year‑over‑year revenue growth and processed volume that has grown 13x since Great Hill Partners' initial investment. Management plans to use the partnership with new investors to drive continued product innovation and further scale the business. One Inc is a China-based provider of cloud software and payments solutions tailored to the insurance industry. Its core offering centers on cloud-based payments and software tools for insurers. The company has completed an extended Series B financing of approximately $35 million. Existing investor H&Q Asia Pacific participated in the extension. The article does not disclose revenue, user metrics, or future product plans. One provides a SaaS platform for insurance companies that combines core insurance functions — policy administration, claims, billing, data analytics, CRM and agency management — with digital engagement solutions. Its platform also supports omni-channel bi-directional payments to enable customer interaction and payments. The company is led by Christopher W. Ewing, President & CEO, and is based in Folsom, CA. One plans to use new funding to expand its reach among insurance carriers, grow its team, and expand globally. Financially, the company has raised over $52m in financing to date. The recent financing increases its resources to pursue broader carrier adoption and international expansion. One provides a SaaS insurance platform that delivers core functions needed by carriers and managing general agencies, including policy administration, billing, rating, agency management, CRM, document management, payment processing, digital engagement, IVR, data warehousing and business intelligence, and e-signature. Led by CEO and founder Christopher W. Ewing, the company positions its product as an end-to-end operating system that consolidates essential insurance workflows. The additional capital will be used to further develop its SaaS platform, add products and lines of business, and expand globally. One has raised $36.7M in total funding to date. The platform targets insurance carriers and managing general agencies seeking a consolidated policy and back-office system. The company is based in Folsom, California. One is a Rancho Cordova, CA–based cloud software provider of core applications for the property and casualty insurance market. It offers InsureOne™, a suite that includes PolicyOne™ (core rating, billing and policy issuance), AppOne™ (agency management), ProcessOne® (payment reconciliation and routing) and DataOne® (data warehouse and business intelligence). Led by CEO Christopher W. Ewing, the company serves customers such as National General Insurance Company, Confie Seguros and Mutual of Enumclaw. One closed a $16.7M Series A to support growth. The company intends to use the funds to build out sales, marketing, implementation and customer service teams.

• Efficient Drivetrains

  Led · Series C · Sep 2016

  Efficient Drivetrains (EDI) designs and markets advanced PHEV and EV drivetrain solutions, including the EDI PowerDrive drivetrain product line, EDI PowerSuite control software, and EDI Power2E exportable power solutions. The company supplies drivetrain and vehicle control technologies to OEMs across North America and the APAC region, with rising orders from work truck, agriculture, logistics, port industries and Asian manufacturers of PHEV passenger, mass transit, and work truck vehicles. EDI reports accelerating customer orders as emissions regulations drive demand for zero-emission vehicle technologies. The company has closed an initial $7.85 million tranche of a planned Series C and is pursuing additional capital to complete a forecasted $15 million round. Planned use of funds includes accelerating mass production of its product lines and expanding manufacturing capacity in the U.S. and China. Efficient Drivetrains (EDI) develops and markets proprietary drivetrain products and technologies for PHEVs, HEVs, and BEVs, claiming significant cost and efficiency advantages for parallel and series hybrid architectures. The company says it has tripled its number of commercial programs over the past year and significantly increased its global customer base. EDI has accelerated plans for a Series B expansion to meet rising North American demand from utility, telecom and military customers and growing interest from Asian manufacturers for PHEV mass-transport applications. The company has already closed $3MM in its Series B round with early participation from an initial cleantech investor. EDI plans to complete the round with additional institutional and angel investors in Q1 2015 and will use proceeds to accelerate product development and strategic alliances. EDI also plans to expand its manufacturing footprint in the U.S. and China to support growth. Efficient Drivetrains, founded in 2006 and based in San Jose, develops and markets proprietary high-efficiency drivetrain technologies for PHEVs, HEVs, and BEVs. Its core products include the EDI Drive PHEV drivetrain system—providing full electric, series, and parallel hybrid performance—and continuously variable transmissions (CVTs) with high efficiency and large torque capacity. The company delivers size, weight, performance, and affordability advantages to vehicle developers, OEMs, and suppliers. EDI is active in automotive projects throughout North America and the APAC region and is expanding operations in Beijing as well as Dixon and Silicon Valley, California. It recently closed a $3.5M Series A to support customer programs and to expand engineering, sales, facilities, and its product roadmap.

• Senhwa Biosciences

  Participated · Series B · Dec 2013

  Senhwa Biosciences focuses on cancer immunotherapy and has been building an AI-powered discovery platform to complement its clinical programs. The company collaborates with emerging AI-native firms and leverages advanced methods — including cell-to-sentence modeling — to probe tumor biology and identify combination therapy opportunities. Its AI-enabled validation has shown promising immunomodulatory potential for lead candidates in specific tumor microenvironments, supporting a ‘‘cold-to-hot tumor’’ strategy to enhance immune responses. Senhwa plans to use the newly secured strategic capital to advance its clinical pipeline, deepen AI integration across discovery and validation, and pursue global expansion and commercialization opportunities. No revenue, user metrics, founding year, or location details were provided in the articles.

• A10 Networks

  Participated · Equity · Jul 2008

  A10 Networks provides application networking and security solutions, including the A10 Thunder Series of Application Delivery Controllers released in May. The Thunder Series is designed to consolidate premium feature modules and increase data center scalability and efficiency. Founded in 2004 by CEO Lee Chen, the company is based in San Jose, California and employs about 600 people across offices in 23 countries. A10 said it will use recent financing to fund R&D, customer support, sales and marketing and to grow its global workforce. The company focuses on accelerating, optimizing and securing applications for enterprise data centers. A10 Networks builds web application delivery products such as server load balancers, bandwidth management appliances, and network identity management appliances. The company is based in San Jose, Calif. Its product portfolio targets application delivery and network performance. A10 reported winning more than 100 new customers since the beginning of the year. The company completed a $23 million third round of funding to support its business. A10 had previously raised $16 million in earlier financings.

No current team members are available.